WrapManager Inc’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.23M | Buy |
5,652
+61
| +1% | +$13.5K | 0.43% | 45 |
|
|
2025
Q4 | $1.28M | Sell |
5,591
-840
| -13% | -$191K | 0.43% | 43 |
|
|
2025
Q3 | $1.49M | Sell |
6,431
-1,399
| -18% | -$285K | 0.46% | 45 |
|
|
2025
Q2 | $1.45M | Sell |
7,830
-2,353
| -23% | -$437K | 0.35% | 56 |
|
|
2025
Q1 | $2.13M | Sell |
10,183
-1,313
| -11% | -$255K | 0.56% | 43 |
|
|
2024
Q4 | $2.04M | Sell |
11,496
-624
| -5% | -$115K | 0.52% | 49 |
|
|
2024
Q3 | $2.39M | Buy |
12,120
+96
| +0.8% | +$17.9K | 0.62% | 41 |
|
|
2024
Q2 | $2.06M | Buy |
12,024
+374
| +3% | +$62K | 0.57% | 43 |
|
|
2024
Q1 | $2.12M | Sell |
11,650
-16
| -0.1% | -$2.76K | 0.59% | 41 |
|
|
2023
Q4 | $1.81M | Buy |
11,666
+331
| +3% | +$48.3K | 0.53% | 52 |
|
|
2023
Q3 | $1.69M | Buy |
11,335
+255
| +2% | +$37.4K | 0.54% | 49 |
|
|
2023
Q2 | $1.49M | Sell |
11,080
-1,365
| -11% | -$200K | 0.46% | 52 |
|
|
2023
Q1 | $1.98M | Buy |
12,445
+10
| +0.1% | +$1.53K | 0.61% | 44 |
|
|
2022
Q4 | $2.01M | Buy |
12,435
+434
| +4% | +$66.5K | 0.65% | 41 |
|
|
2022
Q3 | $1.61M | Sell |
12,001
-64
| -0.5% | -$9.18K | 0.54% | 44 |
|
|
2022
Q2 | $1.85M | Sell |
12,065
-2,880
| -19% | -$440K | 0.58% | 40 |
|
|
2022
Q1 | $2.42M | Sell |
14,945
-2,094
| -12% | -$304K | 0.65% | 37 |
|
|
2021
Q4 | $2.31M | Sell |
17,039
-138
| -0.8% | -$16.3K | 0.58% | 38 |
|
|
2021
Q3 | $1.85M | Sell |
17,177
-387
| -2% | -$44.2K | 0.48% | 49 |
|
|
2021
Q2 | $1.98M | Buy |
17,564
+281
| +2% | +$31.6K | 0.51% | 48 |
|
|
2021
Q1 | $1.87M | Sell |
17,283
-2,221
| -11% | -$238K | 0.52% | 50 |
|
|
2020
Q4 | $2.09M | Sell |
19,504
-1,743
| -8% | -$167K | 0.61% | 41 |
|
|
2020
Q3 | $1.86M | Sell |
21,247
-1,567
| -7% | -$148K | 0.62% | 46 |
|
|
2020
Q2 | $2.24M | Buy |
22,814
+607
| +3% | +$53.4K | 0.83% | 25 |
|
|
2020
Q1 | $1.69M | Buy |
22,207
+5,002
| +29% | +$426K | 0.75% | 23 |
|
|
2019
Q4 | $1.52M | Sell |
17,205
-3,530
| -17% | -$293K | 0.48% | 48 |
|
|
2019
Q3 | $1.57M | Buy |
20,735
+1,697
| +9% | +$116K | 0.52% | 44 |
|
|
2019
Q2 | $1.38M | Sell |
19,038
-510
| -3% | -$40.1K | 0.45% | 58 |
|
|
2019
Q1 | $1.57M | Buy |
19,548
+2,786
| +17% | +$228K | 0.52% | 43 |
|
|
2018
Q4 | $1.54M | Buy |
16,762
+8,577
| +105% | +$754K | 0.55% | 42 |
|
|
2018
Q3 | $774K | Buy |
8,185
+2,742
| +50% | +$260K | 0.25% | 116 |
|
|
2018
Q2 | $504K | Sell |
5,443
-1,206
| -18% | -$118K | 0.17% | 156 |
|
|
2018
Q1 | $629K | Sell |
6,649
-9,019
| -58% | -$991K | 0.21% | 111 |
|
|
2017
Q4 | $1.51M | Sell |
15,668
-11,407
| -42% | -$1.08M | 0.5% | 41 |
|
|
2017
Q3 | $2.41M | Sell |
27,075
-8,804
| -25% | -$670K | 0.81% | 22 |
|
|
2017
Q2 | $2.6M | Sell |
35,879
-169
| -0.5% | -$11.4K | 0.91% | 19 |
|
|
2017
Q1 | $2.35M | Buy |
36,048
+2,851
| +9% | +$179K | 0.86% | 22 |
|
|
2016
Q4 | $2.08M | Sell |
33,197
-1,220
| -4% | -$74.5K | 0.8% | 26 |
|
|
2016
Q3 | $2.17M | Buy |
34,417
+10,088
| +41% | +$653K | 0.85% | 27 |
|
|
2016
Q2 | $1.51M | Buy |
24,329
+1,048
| +5% | +$63.9K | 0.62% | 37 |
|
|
2016
Q1 | $1.33M | Buy |
+23,281
| New | +$1.3M | 0.59% | 45 |
|
Other funds holding ABBV
VCM
VPM
WrapManager Inc's ABBV Position: Q1 2026 in Review
WrapManager Inc increased its AbbVie (ABBV) stake by 1.1% in Q1 2026, buying an estimated $13.5K and bringing the position to 5,652 shares worth $1.23M. The position accounts for 0.43% of the portfolio, ranked #45.
WrapManager Inc first reported a position in ABBV in Q1 2016 and has held it in 41 quarters since. The position peaked at $2.6M in Q2 2017. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- WrapManager Inc held 5,652 shares of AbbVie worth $1.23M as of Q1 2026.
- WrapManager Inc bought 61 AbbVie shares in Q1 2026, an estimated $13.5K.
- AbbVie made up 0.43% of WrapManager Inc's portfolio in Q1 2026, its #45 holding.
- WrapManager Inc first reported a position in AbbVie in Q1 2016 and has held it in 41 quarters since.
- WrapManager Inc's AbbVie position peaked at $2.6M in Q2 2017.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on WrapManager Inc's 13F filing for Q1 2026, filed 11 May 2026.